Genetic Polymorphisms Affect Mouse and Human Trace Amine-Associated Receptor 1 Function
- PMID: 27031617
- PMCID: PMC4816557
- DOI: 10.1371/journal.pone.0152581
Genetic Polymorphisms Affect Mouse and Human Trace Amine-Associated Receptor 1 Function
Abstract
Methamphetamine (MA) and neurotransmitter precursors and metabolites such as tyramine, octopamine, and β-phenethylamine stimulate the G protein-coupled trace amine-associated receptor 1 (TAAR1). TAAR1 has been implicated in human conditions including obesity, schizophrenia, depression, fibromyalgia, migraine, and addiction. Additionally TAAR1 is expressed on lymphocytes and astrocytes involved in inflammation and response to infection. In brain, TAAR1 stimulation reduces synaptic dopamine availability and alters glutamatergic function. TAAR1 is also expressed at low levels in heart, and may regulate cardiovascular tone. Taar1 knockout mice orally self-administer more MA than wild type and are insensitive to its aversive effects. DBA/2J (D2) mice express a non-synonymous single nucleotide polymorphism (SNP) in Taar1 that does not respond to MA, and D2 mice are predisposed to high MA intake, compared to C57BL/6 (B6) mice. Here we demonstrate that endogenous agonists stimulate the recombinant B6 mouse TAAR1, but do not activate the D2 mouse receptor. Progeny of the B6XD2 (BxD) family of recombinant inbred (RI) strains have been used to characterize the genetic etiology of diseases, but contrary to expectations, BXDs derived 30-40 years ago express only the functional B6 Taar1 allele whereas some more recently derived BXD RI strains express the D2 allele. Data indicate that the D2 mutation arose subsequent to derivation of the original RIs. Finally, we demonstrate that SNPs in human TAAR1 alter its function, resulting in expressed, but functional, sub-functional and non-functional receptors. Our findings are important for identifying a predisposition to human diseases, as well as for developing personalized treatment options.
Conflict of interest statement
Figures




Similar articles
-
Trace Amine-Associated Receptor 1 Regulation of Methamphetamine Intake and Related Traits.Neuropsychopharmacology. 2015 Aug;40(9):2175-84. doi: 10.1038/npp.2015.61. Epub 2015 Mar 5. Neuropsychopharmacology. 2015. PMID: 25740289 Free PMC article.
-
A Spontaneous Mutation in Taar1 Impacts Methamphetamine-Related Traits Exclusively in DBA/2 Mice from a Single Vendor.Front Pharmacol. 2018 Jan 22;8:993. doi: 10.3389/fphar.2017.00993. eCollection 2017. Front Pharmacol. 2018. PMID: 29403379 Free PMC article.
-
A breeding strategy to identify modifiers of high genetic risk for methamphetamine intake.Genes Brain Behav. 2021 Feb;20(2):e12667. doi: 10.1111/gbb.12667. Epub 2020 Jun 17. Genes Brain Behav. 2021. PMID: 32424970 Free PMC article.
-
An animal model of differential genetic risk for methamphetamine intake.Front Neurosci. 2015 Sep 23;9:327. doi: 10.3389/fnins.2015.00327. eCollection 2015. Front Neurosci. 2015. PMID: 26441502 Free PMC article. Review.
-
Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies.Int J Mol Sci. 2021 Dec 7;22(24):13185. doi: 10.3390/ijms222413185. Int J Mol Sci. 2021. PMID: 34947997 Free PMC article. Review.
Cited by
-
Facilitating Complex Trait Analysis via Reduced Complexity Crosses.Trends Genet. 2020 Aug;36(8):549-562. doi: 10.1016/j.tig.2020.05.003. Epub 2020 May 29. Trends Genet. 2020. PMID: 32482413 Free PMC article. Review.
-
Torpor: The Rise and Fall of 3-Monoiodothyronamine from Brain to Gut-From Gut to Brain?Front Endocrinol (Lausanne). 2017 May 31;8:118. doi: 10.3389/fendo.2017.00118. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 28620354 Free PMC article. Review.
-
Regional Analysis of the Brain Transcriptome in Mice Bred for High and Low Methamphetamine Consumption.Brain Sci. 2019 Jun 30;9(7):155. doi: 10.3390/brainsci9070155. Brain Sci. 2019. PMID: 31262025 Free PMC article.
-
Reproducibility and replicability of rodent phenotyping in preclinical studies.Neurosci Biobehav Rev. 2018 Apr;87:218-232. doi: 10.1016/j.neubiorev.2018.01.003. Epub 2018 Jan 31. Neurosci Biobehav Rev. 2018. PMID: 29357292 Free PMC article. Review.
-
A platform for experimental precision medicine: The extended BXD mouse family.Cell Syst. 2021 Mar 17;12(3):235-247.e9. doi: 10.1016/j.cels.2020.12.002. Epub 2021 Jan 19. Cell Syst. 2021. PMID: 33472028 Free PMC article.
References
-
- Baud P, Arbilla S, Cantrill RC, Scatton B, Langer SZ. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine. J Pharmacol Exp Ther. 1985;235(1):220–9. Epub 1985/10/01. . - PubMed
-
- Ishida K, Murata M, Kato M, Utsunomiya I, Hoshi K, Taguchi K. Beta-phenylethylamine stimulates striatal acetylcholine release through activation of the AMPA glutamatergic pathway. Biological & pharmaceutical bulletin. 2005;28(9):1626–9. Epub 2005/09/06. . - PubMed
-
- Federici M, Geracitano R, Tozzi A, Longone P, Di Angelantonio S, Bengtson CP, et al. Trace amines depress GABA B response in dopaminergic neurons by inhibiting G-betagamma-gated inwardly rectifying potassium channels. Mol Pharmacol. 2005;67(4):1283–90. Epub 2005/01/13. 10.1124/mol.104.007427 . - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases